2,4,6, tris (2,4-dihydroxyphen) -1,3,5, triazine cas 2125-23-7

CAS 2125-23-7 parameter

Product Name	II, IV: VI, tris (II, IV-dihydroxyphen) -1, III, V, triazine
CAS non.	2125-23-7
Einecs non.	700-796-6
MOLECULA	C21H15N3O6
Pondus	405.36
Usurpo	UV CDLX
Structural formula

CAS 2125-23-7 pluma

1.Structural commoda

In Molecule features a triazine circulum core cum tribus 2,4-dihydroxyphen substituents, formatam extensum conjugated ratio. Hoc structural configuratione confert fortis ultraviolet (UV) effusio capabilities et potentiale photothermal stabilitatem.

II. Physica et eget proprietatibus

Princeps scelerisque stabilitatem: liquiding Point> CCC ° C, Flash Point 285,4 ° C, Density a 1.46 ad 1.586 G / CM³. Huiusmodi idoneam ad summum temperatus processing elit.

Molecular proprietatibus: Molecular Formula C₂₁H₁₅N₃O₆, Molecular pondus 405.36. Videtur quod luteum pulveris et insolubilis in aquis.

CAS 2125-23-7 Application

I. UV praesidio materiae

Primo usus est agriculturae polyvinyl chloride (PVC) films, Engineering Plastics (E.G., Abs, PBT), LATEX coatings et Varnishes. Et incorporationem efficaciter se extendit ad velit ministerium vitae materiae per providing robust UV praesidium.

II. Polymer Material Modification

Act ut ad augendae tempestas resistentiam et impulsum robore plastics ut summus impulsum polystyrene (coxis) et PBT. Applications includit electronic fabrica housings, instrumentation et familia adjumenta.

III. Intermedia ad organicum synthesis

Eget coetus modifications (E.G., Alkylation, Condensal Reactiones) enable synthesis de derivationes ad developing novel conjugated micropomes Polymers (CMPS) vel covalent organicum frameworks (Cfs). Potential applications extend to Gas adsorption, photocatalytic hydrogenii productio et related agris.

IV. Potential biomedical applications

Si pharmacological actio est confirmata, hoc compositis potuit usus est in progressionem antioxidant vel anti-inflammatory medicinae. Praeterea, ut serve sicut chelaing agente in consilio Bioimaging probat.